1887

Abstract

Chlamydial infection of the upper genital tract after abortion is well recognized, but routine screening for infection before termination is rare, and few centres are aware of the prevalence of post-abortion complications in their patient population. Knowledge of the patient population is the best guide for developing screening strategies. The aim of this study was to determine the prevalence of chlamydial infection in patients presenting for legal termination of pregnancy, and to assess the presence of by PCR on specimens collected in either PreservCyt (ThinPrep) or 2-sucrose phosphate (2-SP) transport medium. Two hundred and eleven single, sexually active women, aged 15–26 years, attending the Gynaecology and Obstetric Hospital, Amiens, France, for surgical termination of pregnancy were enrolled in this study from June 2002 to June 2003. detection using a Cobas Amplicor PCR test (Roche Diagnostics) targeting a 207 bp segment of the common cryptic plasmid and a quantitative LightCycler real-time PCR (LC-PCR) (Roche Diagnostics) targeting a 123 bp fragment within the highly conserved constant domain 3 of the single-chromosome-copy gene were performed on endocervical swabs in 2-SP, and on specimens collected using a cytobrush and placed in PreservCyt medium. The in-house LC-PCR was used as a chromosomal diagnosis method and to determine the load of . This method was able to detect the mutant Swedish variant with a deletion of 377 bp in the target area in the cryptic plasmid, which is the region targeted by the Cobas Amplicor PCR test. was detected in 19/211 patients (9 %) by both PCR methods. Among the 19 infected women, was detected by the Cobas Amplicor PCR in 16 specimens in PreservCyt (7.6 %) and in 12 endocervical swabs in 2-SP (5.7 %). Specimens from only nine women were PCR-positive in both PreservCyt and 2-SP media by this method. Cobas Amplicor PCR revealed that 10.9 and 2.3 % of the PreservCyt and 2-SP samples, respectively, contained inhibitors. The same 19 infected women were LC-PCR positive in both PreservCyt and 2-SP samples. No additional infected women were found by this last method; thus, it was concluded that none of the samples contained the new variant of . The load in each sample varied from 10 to 10 copies ml.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.000737-0
2009-01-01
2019-10-20
Loading full text...

Full text loading...

/deliver/fulltext/jmm/58/1/59.html?itemId=/content/journal/jmm/10.1099/jmm.0.000737-0&mimeType=html&fmt=ahah

References

  1. Adderley-Kelly, B. & Stephens, E. M. ( 2005; ). Chlamydia: a major health threat to adolescents and young adults. ABNF J 16, 52–55.
    [Google Scholar]
  2. Anguenot, J. L., de Marval, F., Vassilakos, P., Auckenthaler, R., Ibéchéole, V. & Campana, A. ( 2001; ). Combined screening for Chlamydia trachomatis and squamous intra-epithelial lesions using a single liquid-based cervical sample. Hum Reprod 16, 2206–2210.[CrossRef]
    [Google Scholar]
  3. Bianchi, A., Moret, F., Desrues, J. M., Champenois, T., Dervaux, Y., Desvouas, O., Oursin, A., Quinzat, D., Dachez, R. & other authors ( 2002; ). PreservCyt transport medium used for the Thin Prep Pap Test is a suitable medium for detection of Chlamydia trachomatis by the Cobas Amplicor CT/NG test: results of a preliminary study and future implications. J Clin Microbiol 40, 1749–1754.[CrossRef]
    [Google Scholar]
  4. Blackwell, A. L., Thomas, P. D., Wareham, K. & Emery, S. J. ( 1993; ). Health gains from screening for infection of the lower genital tract in women attending for termination of pregnancy. Lancet 342, 206–210.[CrossRef]
    [Google Scholar]
  5. Cameron, S. T., Stewart, S. & Sutherland, S. ( 2003; ). Can a busy abortion service cope with a screen-and-treat policy for Chlamydia trachomatis infection? Int J STD AIDS 14, 50–54.[CrossRef]
    [Google Scholar]
  6. Cates, W. & Wasserheit, J. N. ( 1991; ). Genital chlamydial infections: epidemiology and reproductive sequelae. Am J Obstet Gynecol 164, 1771–1781.[CrossRef]
    [Google Scholar]
  7. Cates, W., Rolfs, R. T. & Aral, S. O. ( 1990; ). Sexually transmitted diseases, pelvic inflammatory disease, and infertility: an epidemiologic update. Epidemiol Rev 12, 199–220.
    [Google Scholar]
  8. CDC ( 2002; ). Sexually transmitted diseases treatment guidelines 2002. MMWR Recomm Rep 51, 1–78.
    [Google Scholar]
  9. Chernesky, M., Freund, G. G., Hook, E., Leone, P., D'Ascoli, P. & Martens, M. ( 2007; ). Detection of Chlamydia trachomatis and Neisseria gonorrhoeae infections in North American women by testing SurePath liquid-based Pap specimens in APTIMA assays. J Clin Microbiol 45, 2434–2438.[CrossRef]
    [Google Scholar]
  10. de Barbeyrac, B., Tilatti, K., Raherison, S., Mathieu, C., Frantz-Blancpain, S., Clerc, M., Goulet, V., Bébéar, C. & Hocké, C. ( 2006; ). Screening of Chlamydia trachomatis infection in a family planning center and a birth control clinic, Bordeaux, France, 2005. BEH 37–38, 277–279.
    [Google Scholar]
  11. Fiel-Gan, M. D., Villamil, C. F., Mandavilli, S. R., Ludwig, M. E. & Tsongalis, G. J. ( 1999; ). Rapid detection of HSV from cytologic specimens collected into ThinPrep fixative. Acta Cytol 43, 1034–1038.[CrossRef]
    [Google Scholar]
  12. Garland, S. M., Tabrizi, S., Hallo, J. & Chen, S. ( 2000; ). Assessment of Chlamydia trachomatis prevalence by PCR and LCR in women presenting for termination of pregnancy. Sex Transm Infect 76, 173–176.[CrossRef]
    [Google Scholar]
  13. Gomes, J. P., Borrego, M. J., Atik, B., Santo, I., Azevedo, J., Brito de Sa, A., Nogueira, P. & Dean, D. ( 2006; ). Correlating Chlamydia trachomatis infectious load with urogenital ecological success and disease pathogenesis. Microbes Infect 8, 16–26.[CrossRef]
    [Google Scholar]
  14. Groom, T. M., Stewart, P., Kruger, H. & Bell, G. ( 2001; ). The value of a screen and treat policy for Chlamydia trachomatis in women attending for termination of pregnancy. J Fam Plann Reprod Health Care 27, 69–72.[CrossRef]
    [Google Scholar]
  15. Hamdad, F., Orfila, J., Boulanger, J. C. & Eb, F. ( 2004; ). Chlamydia trachomatis urogenital infection in women. Best diagnosis approaches. Gynecol Obstet Fertil 32, 1064–1074.[CrossRef]
    [Google Scholar]
  16. Hamdad-Daoudi, F., Petit, J. & Eb, F. ( 2004; ). Assessment of Chlamydia trachomatis infection in asymptomatic male partners of infertile couples. J Med Microbiol 53, 985–990.[CrossRef]
    [Google Scholar]
  17. Hopwood, J., Mallinson, H., Hodgson, E. & Hull, L. ( 2004; ). Liquid based cytology: examination of its potential in a chlamydia screening programme. Sex Transm Infect 80, 371–373.[CrossRef]
    [Google Scholar]
  18. Inhorn, S. L., Wand, P. J., Wright, T. C., Hatch, K. D., Hallum, J. & Lentrichia, B. B. ( 2001; ). Chlamydia trachomatis and Pap testing from a single, fluid-based sample. A multicenter study. J Reprod Med 46, 237–242.
    [Google Scholar]
  19. Keegan, H., Boland, C., Malkin, A., Griffin, M., Ryan, F. & Lambkin, H. ( 2005; ). Comparison of DNA extraction from cervical cells collected in PreservCyt solution for the amplification of Chlamydia trachomatis. Cytopathology 16, 82–87.[CrossRef]
    [Google Scholar]
  20. Koumans, E. H., Black, C. M., Markowitz, L. E., Unger, E. R., Pierce, A., Sawyer, M. K. & Papp, J. R. ( 2003; ). Comparison of methods for detection of Chlamydia trachomatis and Neisseria gonorrhoeae using commercially available nucleic acid amplification tests and a liquid pap smear medium. J Clin Microbiol 41, 1507–1511.[CrossRef]
    [Google Scholar]
  21. LaMontagne, D. S., Pimenta, J. M., Fenton, K. A., Mallison, H. & Howood, J. ( 2004; ). Management of genital chlamydial infections at termination of pregnancy services in England and Wales: where are we now? BJOG 111, 1408–1412.[CrossRef]
    [Google Scholar]
  22. Mallinson, H., Hopwood, J., Skidmore, S., Frenton, K., Phillips, C. & Jones, I. ( 2002; ). Provision of chlamydia testing in a nationwide service offering termination of pregnancy: with data capture to monitor prevalence of infection. Sex Transm Infect 78, 416–421.[CrossRef]
    [Google Scholar]
  23. Mertz, K. J., Ransom, R. L., St Louis, M. E., Groseclose, S. L., Hadgu, A., Levine, W. C. & Hayman, C. ( 2001; ). Prevalence of genital chlamydial infection in young women entering a national job training program, 1990–1997. Am J Public Health 91, 1287–1290.[CrossRef]
    [Google Scholar]
  24. Ripa, T. & Nilsson, P. A. ( 2007; ). A Chlamydia trachomatis strain with a 377-bp deletion in the cryptic plasmid causing false-negative nucleic acid amplification tests. Sex Transm Dis 34, 255–256.
    [Google Scholar]
  25. Scholes, D., Stergachis, A., Heidrich, F. E., Andrilla, H., Holmes, K. K. & Stamm, W. E. ( 1996; ). Prevention of pelvic inflammatory disease by screening for cervical chlamydial infection. N Engl J Med 23, 1362–1366Medline
    [Google Scholar]
  26. Simms, I., Stephenson, J. M., Mallison, H., Peeling, R. W., Thomas, K., Gokhale, R., Rogers, P. A., Hay, P., Oakeshott, P. & other authors ( 2006; ). Risk factors associated with pelvic inflammatory disease. Sex Transm Infect 82, 452–457.[CrossRef]
    [Google Scholar]
  27. Solomon, A. W., Holland, M. J., Burton, M. J., West, S. K., Alexander, N. D., Aguirre, A., Massae, P. A., Mkocha, H., Munoz, B. & other authors ( 2003; ). Strategies for control of trachoma: observational study with quantitative PCR. Lancet 362, 198–204.[CrossRef]
    [Google Scholar]
  28. Verkooyen, R. P., Luijendijk, A., Huisman, W. M., Goessens, W. H., Kluytmans, J. A., Van Rijsoort-Vos, J. H. & Verbrugh, H. A. ( 1996; ). Detection of PCR inhibitors in cervical specimens by using the AMPLICOR Chlamydia trachomatis assay. J Clin Microbiol 34, 3072–3074.
    [Google Scholar]
  29. Westrom, L. ( 1987; ). Pelvic inflammatory disease: bacteriology and sequelae. Contraception 36, 111–128.[CrossRef]
    [Google Scholar]
  30. Zhang, W., Cohenford, M., Lentrichia, B., Isenberg, H. D., Simson, E., Li, H., Yi, J. & David, Y. ( 2002; ). Detection of Chlamydia trachomatis by isothermal ramification amplification method: a feasibility study. J Clin Microbiol 40, 128–132.[CrossRef]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.000737-0
Loading
/content/journal/jmm/10.1099/jmm.0.000737-0
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error